Literature DB >> 15286321

Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty--are there clinical predictors of patency?

Dheeraj K Rajan1, Sarah Bunston, Sanjay Misra, Ruxandra Pinto, Charmaine E Lok.   

Abstract

PURPOSE: To determine the primary and secondary patency rates for fistulas treated with angioplasty, as well as clinical predictors of fistula patency after angioplasty.
MATERIALS AND METHODS: The authors reviewed their institutional experience with autogenous fistulas from June 1997 to June 2002. A total of 104 men and 36 women were treated. Mean age +/- standard deviation of patient cohort was 62.4 years +/- 15.6. Patient age and sex, age of fistula at initial intervention, presence of diabetes, side and location of fistula, location of stenosis, and number of venous stenoses dilated were examined. Patency after angioplasty was estimated by using the Kaplan-Meier method, and predictors of patency were examined by using a Cox proportional hazards model.
RESULTS: One hundred fifty-one dysfunctional fistulas (94 radiocephalic and 57 brachiocephalic) were treated with angioplasty initially. Clinical success rate was 98.0% (297 of 303 interventions). At 3, 6, and 12 months, respectively, primary patency rates +/- standard errors of the estimate were 73% +/- 6, 51% +/- 7, and 39% +/- 7 for brachiocephalic fistulas and 85% +/- 4, 75% +/- 5, and 62% +/- 5 for radiocephalic fistulas; secondary patency rates were 96% +/- 2.4, 89% +/- 4, and 85% +/- 5 for brachiocephalic fistulas and 91% +/- 3, 88% +/- 3, and 86% +/- 4 for radiocephalic fistulas. For all time points, there was a significant difference in primary (P =.004) but not secondary (P =.45) patency between radiocephalic and brachiocephalic fistulas. Stenosis was most prevalent within 3 cm of the arteriovenous anastomosis in 74 (64%) of the 116 dysfunctional radiocephalic fistulas and at the cephalic arch in 22 (30%) of the 74 dysfunctional brachiocephalic fistulas. The clinical variables examined did not influence outcome. Complications occurred in seven (2.3%) of 303 interventions.
CONCLUSION: Patency after angioplasty in dysfunctional autogenous hemodialysis fistulas exceeds that observed in hemodialysis grafts. None of the clinical or anatomic variables examined affected patency outcome. Copyright RSNA, 2004

Entities:  

Mesh:

Year:  2004        PMID: 15286321     DOI: 10.1148/radiol.2322030714

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis.

Authors:  Hui Xue; Eduardo Lacson; Weiling Wang; Gary C Curhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

2.  Percutaneous transluminal angioplasty for dysfunctional femoral hemodialysis graft.

Authors:  Eunsun Oh; Yong Jae Kim; Dong Erk Goo; Seungboo Yang; Seongsook Hong
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

3.  C-reactive protein variability is associated with vascular access outcome in hemodialysis patients.

Authors:  Wei-Hung Kuo; Yueh-Ting Lee; Hwee-Yeong Ng; Chun-Yeh Wang; Chien-Hsing Wu; Chien-Te Lee
Journal:  J Clin Lab Anal       Date:  2017-04-27       Impact factor: 2.352

4.  Bedside screening for fistula stenosis should be tailored to the site of the arteriovenous anastomosis.

Authors:  Nicola Tessitore; Valeria Bedogna; Giovanni Lipari; Edoardo Melilli; William Mantovani; Elda Baggio; Antonio Lupo; Giancarlo Mansueto; Albino Poli
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

5.  Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency.

Authors:  Ayse Aktas; Alper Bozkurt; Bulent Aktas; Ismail Kirbas
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

Review 6.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

7.  Plasma ADMA predicts restenosis of arteriovenous fistula.

Authors:  Chih-Cheng Wu; Szu-Chi Wen; Chung-Wei Yang; Shih-Yun Pu; Kuei-Chin Tsai; Jaw-Wen Chen
Journal:  J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 10.121

8.  MicroRNA-21 and Venous Neointimal Hyperplasia of Dialysis Vascular Access.

Authors:  Chih-Cheng Wu; Li-Jing Chen; Mu-Yang Hsieh; Chien-Ming Lo; Ming-Hsien Lin; Hsiao-En Tsai; Hsiang-Lin Song; Jeng-Jiann Chiu
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-21       Impact factor: 8.237

9.  Evaluation of Venous Stenosis Angioplasty in a Murine Arteriovenous Fistula Model.

Authors:  Chuanqi Cai; Binxia Yang; Sreenivasulu Kilari; Yiqing Li; Chenglei Zhao; Amit Sharma; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2019-03-20       Impact factor: 3.464

10.  Predictors of primary patency after percutaneous balloon angioplasty for stenosis of Brescia-Cimino hemodialysis arteriovenous fistula.

Authors:  Zheng-Rong Zhu; Lan Zou; Yue Xing; Yu-Can Tan; Guo-Jian Xu; Zhi-Jian He; Jian-Qiang Cao; Jia-Yu Wu; Xiao-Xia Liang; Hui-Ping Zhang; Yan-Hong Tan; Can-Hua Luo
Journal:  Br J Radiol       Date:  2020-03-04       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.